Cargando…
Intermittent Administration of Parathyroid Hormone 1–34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ
Human mesenchymal stem cells (hMSCs) can differentiate into osteoblasts and are regulated by chemical cues. The recombinant N-terminal (1–34 amino acids) fragment of the parathyroid hormone (PTH (1–34)) is identified to promote osteogenesis. The osteoanabolic effects of intermittent PTH (1–34) treat...
Autores principales: | Kuo, Shu-Wen, Rimando, Marilyn G., Liu, Yi-Shiuan, Lee, Oscar K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666900/ https://www.ncbi.nlm.nih.gov/pubmed/29064396 http://dx.doi.org/10.3390/ijms18102221 |
Ejemplares similares
-
Optimal timing for intermittent administration of parathyroid hormone (1–34) for distraction osteogenesis in rabbits
por: Inada, Narisaku, et al.
Publicado: (2022) -
Effects of Intermittent Parathyroid Hormone 1–34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women
por: Tang, Yutao, et al.
Publicado: (2019) -
Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone
por: Ogura, Kenji, et al.
Publicado: (2016) -
Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs)
por: Rimando, Marilyn G., et al.
Publicado: (2016) -
The Transcription Factor Foxc1 Promotes Osteogenesis by Directly Regulating Runx2 in Response of Intermittent Parathyroid Hormone (1–34) Treatment
por: Ouyang, Ningjuan, et al.
Publicado: (2020)